SUBSCRIBE
SUBSCRIBE

Australia

Dark Chocolate May Help Lower Blood Pressure, National Institute of Integrative Medicine Study
August 16, 2012
 · 
1 min read
Low Sex Hormone May Increase Autistic Symptoms, University of Otago Study
August 15, 2012
 · 
1 min read
Fainting: A Twin Thing? University of Melbourne Study
August 7, 2012
 · 
1 min read
Low-Risk People Benefit From Heart Drugs, University of Sydney Study
August 6, 2012
 · 
1 min read
Bayer HealthCare Test Drug Contributed to Death
August 2, 2012
 · 
1 min read
High Testosterone Levels Can Speed Up Prostate Cancer, University of Western Australia Study
August 2, 2012
 · 
1 min read
Scientists Discover Possible Antibiotics Alternative, Monash University Study
July 30, 2012
 · 
1 min read
Alcohol Can Triple Original Dose of Medicine, Monash University Reveals
July 27, 2012
 · 
1 min read
How Breast Cancer Cells Damage Bones, Peter MacCallum Cancer Centre Study
July 23, 2012
 · 
1 min read
Differences in Twins’ DNA Set in the Womb, Murdoch Children’s Research Institute Study
July 16, 2012
 · 
1 min read
Load More
PRESS RELEASES
Press Releases
Amplia Therapeutics to Present at 2026 ASCO Gastrointestinal Cancers Symposium
December 24, 2025
 · 
2 min read
Press Releases
Kazia Therapeutics Regains Full Nasdaq Listing Compliance
December 23, 2025
 · 
3 min read
Press Releases
Immutep Announces Positive Update on IMP761, a First-in-Class LAG-3 Agonist Antibody for Autoimmune Diseases, from Phase I Study
December 23, 2025
 · 
5 min read
Press Releases
Propanc Biopharma Publishes Impact of Proenzymes on Pancreatic Ductal Adenocarcinoma Fibroblasts in Peer Reviewed Journal
December 23, 2025
 · 
4 min read
Press Releases
Precision Medicine Portfolio Update: Illuccix China Phase 3 Study, TLX101-CDx and TLX250-CDx FDA Resubmissions
December 22, 2025
 · 
11 min read
Press Releases
Final, 247th participant randomized and commences treatment in Actinogen’s XanaMIA pivotal phase 2b/3 Alzheimer’s trial
December 19, 2025
 · 
8 min read
Press Releases
Vir Biotechnology Grants Norgine Exclusive Commercial License to Chronic Hepatitis Delta Treatment Candidate in Europe, Australia & New Zealand, Including Global Cost Sharing Agreement for Ongoing ECLIPSE Clinical Development Program
December 17, 2025
 · 
9 min read
Press Releases
Immutep Announces Strong Operational Progress in Global TACTI-004 (KEYNOTE-F91) Phase III and Enrolment Continues at Robust Pace
December 17, 2025
 · 
4 min read
Press Releases
Novotech Issues White Paper to Help Sponsors Strengthen Early-Phase Oncology Strategy and Execution
December 16, 2025
 · 
3 min read
Press Releases
Radiopharm Theranostics Achieves Primary Endpoint in 92% of Patients at Interim Analysis of RAD 101 Phase 2b Imaging Trial in Brain Metastases
December 15, 2025
 · 
5 min read
Press Releases
Patient Enrolment Completed in Phase 2 aGvHD Clinical Trial
December 15, 2025
 · 
4 min read
Press Releases
FDA Clears NUZ-001 for Entry into HEALEY ALS Platform Trial
December 12, 2025
 · 
4 min read
Press Releases
Aardvark Therapeutics Announces First Patient Dosed in Australia in HERO Phase 3 Trial for Prader-Willi Syndrome
December 11, 2025
 · 
6 min read
Press Releases
Kazia Therapeutics Highlights New Clinical and Translational Findings Demonstrating Paxalisib’s Ability to Reinvigorate Anti-Tumor Immunity Across Multiple Advanced Breast Cancer Populations including TNBC and HER2+
December 10, 2025
 · 
9 min read
Press Releases
Telix and Varian Announce Strategic Theranostics-EBRT Clinical Collaboration
December 10, 2025
 · 
13 min read
Press Releases
AdvanCell Receives First Delivery of High-Activity Thorium-228, Highlighting a Unique Industry Capability and Expertise Essential to Scaling Lead-212 Production for Targeted Alpha Therapies
December 9, 2025
 · 
4 min read
Press Releases
CLINUVEL expands Singapore RD&I Centre to pioneer next-generation peptide therapies
December 8, 2025
 · 
7 min read
Press Releases
Key Narmafotinib Patent Granted in the U.S.
December 4, 2025
 · 
2 min read
Press Releases
AdvanCell Initiates Phase 2 Expansion Trial of ADVC001, a Novel Targeted Alpha Therapy for Prostate Cancer
December 3, 2025
 · 
4 min read
Press Releases
CYIOS Corp. Appoints John O’Shea as Chief Executive Officer to Lead Next Phase of Growth and Innovation
December 3, 2025
 · 
5 min read
Load More